Key terms

About ATR

AptarGroup, Inc. engages in the design, manufacture, drug delivery, consumer product dispensing, sealing and active packaging solutions, and services for the prescription drug, consumer health care, injectable, active packaging, beauty, personal care, home care, and food and beverages industries. It operates through the following segments: Pharma, Beauty and Home, and Food and Beverage. The company was founded in 1940 and is headquartered in Crystal Lake, IL.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ATR news

Mar 07 7:07am ET AptarGroup price target raised to $160 from $157 at Wells Fargo Feb 29 5:30am ET Analysts Offer Insights on Healthcare Companies: Arcellx Inc (ACLX), Sarepta Therapeutics (SRPT) and AptarGroup (ATR) Feb 13 7:20am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: AptarGroup (ATR), Halozyme (HALO) and Bausch Health Companies (BHC) Feb 12 6:09am ET AptarGroup price target raised to $157 from $152 at Wells Fargo Feb 12 5:55am ET AptarGroup: Strong Buy on Pharma Growth and Operational Efficiency Feb 11 11:55am ET AptarGroup’s Strong Performance and Growth Prospects Merit a Buy Rating Feb 10 1:02am ET Bad News for AptarGroup, Inc. Stock: This New Risk Has Been Added Feb 09 10:03am ET Aptar Digital Health enters enterprise agreement with Biogen Feb 08 5:07pm ET AptarGroup sees Q1 EPS $1.10-$1.18, consensus $1.12 Feb 08 5:06pm ET AptarGroup reports Q4 adjusted EPS $1.21, consensus $1.12 Jan 15 12:35am ET AptarGroup: A Strong Buy on Pharmaceutical Growth and Valuation Upside Jan 11 10:20am ET The container and packaging stocks to own in 2024, according to Wells Fargo Jan 11 10:20am ET The container and packaging stocks to own in 2024, according to Wells Fargo Jan 03 5:10am ET AptarGroup upgraded to Outperform from Neutral at Baird Jan 03 4:06am ET AptarGroup: A Strong Buy on Earnings Growth and Strategic Segment Improvements

No recent press releases are available for ATR

ATR Financials

1-year income & revenue

Key terms

ATR Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ATR Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms